BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6157044)

  • 1. Natural cytotoxicity in humans: susceptibility of freshly isolatd tumor cells to lysis.
    Vose BM; Moore M
    J Natl Cancer Inst; 1980 Aug; 65(2):257-63. PubMed ID: 6157044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
    Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to natural killer cell-mediated cytolysis by a pleiotropic drug-resistant human erythroleukemia (K562-R) cell line.
    Yanovich S; Hall RE; Weinert C
    Cancer Res; 1986 Sep; 46(9):4511-5. PubMed ID: 2425955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
    Uchida A; Moore M
    J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell activity and autologous tumor killing activity in cancer patients: overlapping involvement of effector cells as determined in two-target conjugate cytotoxicity assay.
    Uchida A; Yanagawa E
    J Natl Cancer Inst; 1984 Nov; 73(5):1093-100. PubMed ID: 6593485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
    Uchida A; Micksche M
    J Natl Cancer Inst; 1983 Oct; 71(4):673-80. PubMed ID: 6413742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural cytotoxic activity in human lungs.
    Bordignon C; Villa F; Vecchi A; Giavazzi R; Introna M; Avallone R; Mantovani A
    Clin Exp Immunol; 1982 Feb; 47(2):437-44. PubMed ID: 6176378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of different types of interferon on the natural cellular cytotoxicity of lung cancer patients].
    Avdeev GI; Viadro MM; Leĭkin IuD; Kuznetsov VP; Trakhtenberg AKh
    Eksp Onkol; 1986; 8(3):44-6. PubMed ID: 2424715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytotoxic action of natural killer cells on human tumor cells].
    Avdeev GI; Viadro MM; Leĭkin IuD; Timofeevskaia EA; Osipov SG
    Biull Eksp Biol Med; 1985 Apr; 99(4):471-3. PubMed ID: 3986372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cells kill human retinoblastoma cells.
    Ohashi Y; Sasabe T; Nishida T; Manabe R
    Jpn J Ophthalmol; 1984; 28(4):370-6. PubMed ID: 6085129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
    Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
    J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer.
    Mizutani Y; Okada Y; Terachi T; Yoshida O
    J Urol; 1996 Mar; 155(3):888-92; discussion 892-4. PubMed ID: 8583600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human NK cell cytotoxicity against K562 cells with glycopeptides from K562 plasma membranes.
    Decker JM; Hinson A; Ades EW
    J Clin Lab Immunol; 1984 Nov; 15(3):137-43. PubMed ID: 6397595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel telomerase-based approach to detect natural cell-mediated cytotoxic activity against tumor cells in vitro.
    Faraoni I; Cottarelli A; Giuliani A; Bonmassar L; Rossi L; Bonmassar E
    J Immunol Methods; 2005 Oct; 305(2):162-72. PubMed ID: 16165149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-induced changes in the susceptibility of murine and human lymphoma cells to natural cytotoxic lymphocytes.
    Giuliani-Bonmassar A; Graziani G; Frati L; Bonmassar E
    Int J Tissue React; 1984; 6(1):35-41. PubMed ID: 6585352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of various interferons on the spontaneous cytotoxicity exerted by lymphocytes from normal and tumor-bearing patients.
    Lucero MA; Fridman WH; Provost MA; Billardon C; Pouillart P; Dumont J; Falcoff E
    Cancer Res; 1981 Jan; 41(1):294-9. PubMed ID: 6160906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.